# Jean-­Marc Ferrero

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jean-marc-ferrero/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,640 |
| Field | Breast Cancer Treatment Studies |
| h-index | 60 |
| i10-index | 157 |
| Last Known Institution | Université Côte d'Azur |
| OpenAlex ID | https://openalex.org/A5032686530 |
| ORCID iD | https://orcid.org/0000-0003-0069-3743 |
| Works | 398 |

## Researcher papers

- [Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/pertuzumab-trastuzumab-and-docetaxel-for-her2-positive-metastatic-breast-cancer/)
- [Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial](https://scholariq.org/papers/capivasertib-plus-paclitaxel-versus-placebo-plus-paclitaxel-as-first-line/)
- [Prognostic factors in 1038 women with metastatic breast cancer](https://scholariq.org/papers/prognostic-factors-in-1038-women-with-metastatic-breast-cancer/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Researcher university

- [Université Côte d'Azur](https://scholariq.org/institutions/universite-cote-d-azur/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.